partnership announcement s2n health and medtech innovator

MedTech Innovator and S2N Health Partner Announce Partnership for Value Program Participants

Startups in the 2022 MedTech Innovator Accelerator Program to Leverage S2N’s RepSignal Market Intelligence Platform

LOS ANGELES and BOSTON- November 2, 2022– S2N Health, a strategy services and software provider for medical device companies, and MedTech Innovator, the largest life science accelerator in the world, today announced a partnership in which S2N’s AI-powered customer and market intelligence platform, RepSignal, is being harnessed by MedTech Innovator’s early-stage Accelerator companies as part of MedTech Innovator’s 2022 Value Program.

2022 MedTech Innovator Accelerator companies are able to leverage RepSignal’s
powerful insights on target clinical users of their technologies during the program to better define their market opportunities and identify potential trial sites, early adopters, and KOLs in their target areas. Winners of this year’s Value competition, to be announced at the MedTech Strategist Innovation Summit November 14-16, 2022, in San Francisco, will also receive full access to the RepSignal platform to support their commercial planning.

S2N and especially Amy Siegel, have been incredible supporters of the MedTech Innovator program by providing critical insight and guidance to our Accelerator startups,” said Paul Grand, CEO of MedTech Innovator. “We are thrilled and grateful to the S2N Health team for providing our MTI Value Program participants the opportunity to leverage their RepSignal platform. It’s an invaluable tool that will help our startups in their commercialization and market planning.

We are honored to be part of the incredible MedTech Innovator ecosystem, and excited to be
contributing RepSignal’s powerful insights and analytics to this year’s Value Program
participants,” said Amy Siegel, CEO and Co-founder of S2N Health and long-time judge and
advisor to MedTech Innovator companies. “We look forward to awarding RepSignal to the Value
Award winners at the MedTech Strategist Innovation Summit.

About S2N Health

S2N Health provides cutting-edge strategy consulting services and software solutions to medical technology companies to maximize the impact and success of their innovations. Since 2011, S2N Health has worked with more than 160 companies, from start-ups to large global organizations, bringing critical insights and analytics to key product, commercial and business decisions. S2N supports clients at all stages, including development, market entry, sales acceleration, and strategic partnering. In 2022, S2N introduced RepSignal, an AI-driven software solution delivering on-demand customer insights and intelligence to med tech commercial teams for successfully targeting and engaging clinical customers. To learn more about S2N Health and RepSignal, visit the website and follow S2N Health on LinkedIn.

About MedTech Innovator

Based in Los Angeles, Calif., MedTech Innovator is the largest accelerator of medical device companies in the world and the premier nonprofit startup accelerator in the medical technology industry. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the health care system. MedTech Innovator matches health care industry leaders with innovative early-stage and emerging-growth medtech companies for mentorship and support. For more information about MedTech Innovator, visit and follow @MedTechAwards on Twitter and on LinkedIn. To receive industry insights and highlights about MedTech Innovator’s current and alumni participant companies, subscribe to its monthly newsletter.